drugset / Trial / NCT00786552
Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The aims of this trial are to evaluate the efficacy and tolerability of pemetrexed + paclitaxel in patients with recurrent/advanced follicular, papillary or anaplastic thyroid cancer.
Timeline
- Start
- 2008-11
- Primary completion
- 2012-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | 90 mg/m2 | Intravenous |
| Subject | Pemetrexed | Small molecule | 500 mg/m2 | Intravenous |